ArticleHereditas2026

TLE1 as a key regulator of osimertinib resistance and EMT in lung adenocarcinoma: implications for prognosis and immunotherapy response.

Na Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.